Liver Disease Treatment Market Report 2022-2027: Size, Share, Industry Growth, Analysis

Liver Disease Treatment Market Report

The global liver disease treatment market size reached US$ 20.83 billion in 2021. By 2027, it will reach US$ 30.91 billion, growing at a CAGR of 6.50%.

SHERIDAN, WYOMING, USA, September 16, 2022 /EINPresswire.com/ — The latest research study “Liver Disease Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” by IMARC Group concludes that the global liver disease treatment market reached a value of US$20.83 billion in 2021. Looking ahead, IMARC Group expects the market to reach a value of US$30.91 billion by 2027, with a CAGR by 6.50% over the period 2022-2027.

The liver is a vital organ in the human body that performs various functions such as separating nutrients and waste products as they move through the digestive system, removing harmful substances from the blood, and maintaining an adequate balance of products chemicals in the body. Liver disease can be hereditary or caused by various factors such as viruses, alcohol, and obesity. These conditions can lead to scarring (cirrhosis) or liver failure, if not treated at an early stage. Accordingly, the treatment of liver disease plays a vital role in improving cholesterol, hormone excretion, bile synthesis and enzyme activation.

Request a free sample PDF for more detailed market information: https://www.imarcgroup.com/liver-disease-treatment-market/requestsample

Note: We regularly track the direct effect of COVID-19 on the market, as well as the indirect influence of associated industries. These observations will be incorporated into the report.

Liver Disease Treatment Market Trends and Drivers:

The growing geriatric population, which is more susceptible to chronic diseases including liver disease, represents one of the major factors driving the market growth. In addition, the increasing prevalence of fatty liver disease caused by high cholesterol and blood pressure levels, obesity and diabetes acts as another major growth factor.

In addition to this, the introduction of various technological advancements, such as bioartificial liver, which is widely used for patients suffering from acute liver failure, is also contributing to the growth of the market. Additionally, there has been a significant increase in the use of antiviral drugs to suppress the hepatitis B virus and reduce the risk of developing cirrhosis and hepatocellular carcinoma.

This, coupled with the expansion of the healthcare sector, creates a positive market outlook. Additionally, governments in many countries are undertaking initiatives to promote public healthcare, which is expected to provide positive market prospects in the coming years.

2022-2027 Global Liver Disease Treatment Market Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the major players operating in the market.

Some major key players:

Abbott Laboratories, AbbVie Inc., Astellas Pharma Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Emergent BioSolutions Inc., F. Hoffmann-La Roche AG, Gilead Sciences Inc., GlaxoSmithKline plc, Merck & Co. Inc. , Novartis AG, Pfizer Inc., Sanofi SA, Takeda Pharmaceutical Company Limited and Viatris Inc.

Ask the analyst for a customization and explore the full report with table of contents and list of figures: https://www.imarcgroup.com/liver-disease-treatment-market

The report has segmented the market based on region, treatment type, disease type, and end user.

Breakdown by type of treatment:
• Antiviral drugs
• Immunosuppressants
• Vaccines
• Immunoglobulins
• Corticosteroids
• Targeted therapy
• Chemotherapy

Breakdown by type of illness:
• Hepatitis
• Autoimmune diseases
Non-alcoholic fatty liver disease (NAFLD)
• Cancer
• Genetic disorders
• Others

Breakdown by end user:
• Hospitals
• Ambulatory surgery centers
• Others

Breakdown by region:
• North America: (United States, Canada)
• Asia-Pacific: (China, Japan, India, South Korea, Australia, Indonesia, others)
• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America: (Brazil, Mexico, others)
• Middle East and Africa

If you want the latest primary and secondary data (2022-2027) with cost module, business strategy, distribution channel, etc. Click request a free sample report, the published report will be emailed to you in PDF format within 24-48 hours of receipt. full payment.

Main highlights of the report:
• Market performance (2016-2021)
• Market Outlook (2022-2027)
• Porter’s five forces analysis
• Market drivers and success factors
• SWOT analysis
• Value chain
• Complete mapping of the competitive landscape

If you need specific information that is not currently covered in the report, we can provide it to you as part of the customization.

Browse IMARC Group Other Latest Research Reports:

Veterinary Imaging Market Size 2022-2027: https://www.digitaljournal.com/pr/veterinary-imaging-market-size-2022-2027-share-trends-industry-growth-analysis-and-forecast-imarc-group

2022-2027 Continuous Glucose Monitoring Systems Market Share: https://www.digitaljournal.com/pr/continuous-glucose-monitoring-systems-market-share-size-trends-growth-analysis-and-forecast-to-2022-2027

Mucous Atomization Devices Market Report 2022-2027: https://www.digitaljournal.com/pr/mucosal-atomization-devices-market-is-set-to-expand-at-a-cagr-of-7-12-to-reach-s-1045-20- million-by-2027-imarc-group

Neonatal Ventilator Market Size 2022-2027: https://www.digitaljournal.com/pr/neonatal-ventilator-market-predicted-to-generate-us-547-2-million-and-grow-at-6-60-cagr-in-the-2022- forecast-period-2027-confirmed-by-imarc-group

Cancer Cachexia Market Size 2022-2027: https://www.digitaljournal.com/pr/cancer-cachexia-market-size-to-reach-us-2-53-billion-by-2027-imarc-group

About Us:

The IMARC Group is a leading market research firm providing management strategies and market research worldwide. We partner with clients across all industries and geographies to identify their most important opportunities, address their most critical challenges and transform their businesses.

IMARC’s information products include major business, scientific, economic and technological developments for business leaders in pharmaceutical, industrial and high-tech organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverages, travel and tourism, nanotechnology and new processing methods are at the top of the list. company expertise.

Contact us:

IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, Wyoming 82801 USA – Wyoming
Email: [email protected]
Such. :(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe:- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Elena Anderson
IMARC Services Private Limited
+1 6317911145
write to us here

Comments are closed.